Amy Abernethy, the principal deputy commissioner and acting CIO of the Food and Drug Administration, discusses the agency’s plans to update its data strategy and technology to move with the speed of scientific advancement. Abernethy also explains the importance of leveraging innovative technology like AI and blockchain, migrating to the cloud, and public-private partnerships supporting the agency’s COVID-19 response efforts.
HealthCast
Season 1
Episode 23
29m listen
FDA’s Technology Modernization Vision
Share
FDA is modernizing its technology infrastructure to accelerate scientific and regulatory decisions.
-
Amy Abernethy Principal Deputy Commissioner and Acting CIO FDA
Related Content
-
Marine Warfighting Lab Turns Lessons from Ukraine into Future Strategy
The Marine Corps Warfighting Laboratory uses wargaming and simulation to analyze threats, test capabilities and prepare for future conflicts.
12m listen -
Former DOL CISO on the Importance of Building Your Network
Paul Blahusch discusses leveraging your network and the power of pivoting.
7m watch -
Inside DOE’s Genesis Mission to Power AI-Driven Science
Rick Stevens explains how DOE’s Genesis mission is integrating supercomputing, AI and quantum technologies to accelerate scientific discovery.
25m watch -
NOAA Improves Geospatial Accuracy With NSRS Modernization
NOAA is integrating GPS and new gravity data to improve accuracy of its National Spatial Reference System.
9m listen
